GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sharps Technology Inc (NAS:STSSW) » Definitions » ROCE %

Sharps Technology (Sharps Technology) ROCE % : -97.57% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sharps Technology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sharps Technology's annualized ROCE % for the quarter that ended in Mar. 2024 was -97.57%.


Sharps Technology ROCE % Historical Data

The historical data trend for Sharps Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sharps Technology ROCE % Chart

Sharps Technology Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROCE %
-109.48 -170.80 -134.77 -112.97

Sharps Technology Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -88.34 -101.08 -95.91 -123.62 -97.57

Sharps Technology ROCE % Calculation

Sharps Technology's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-10.127/( ( (11.84 - 2.007) + (11.789 - 3.693) )/ 2 )
=-10.127/( (9.833+8.096)/ 2 )
=-10.127/8.9645
=-112.97 %

Sharps Technology's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-7.376/( ( (11.789 - 3.693) + (9.804 - 2.781) )/ 2 )
=-7.376/( ( 8.096 + 7.023 )/ 2 )
=-7.376/7.5595
=-97.57 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sharps Technology  (NAS:STSSW) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Sharps Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Sharps Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sharps Technology (Sharps Technology) Business Description

Traded in Other Exchanges
Address
105 Maxess Road, Suite 124, Melville, NY, USA, 11747
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa ultra-low waste smart safety syringes are designed to eliminate over two million potentially infectious and accidental needlestick injuries.

Sharps Technology (Sharps Technology) Headlines

From GuruFocus

Sharps Technology Announces Letter to Shareholders

By GuruFocusNews GuruFocusNews 06-08-2022

Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023

By Stock market mentor Stock market mentor 01-10-2023